228 related articles for article (PubMed ID: 35187241)
1. Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden.
Angelis A
MDM Policy Pract; 2018; 3(2):2381468318796218. PubMed ID: 35187241
[No Abstract] [Full Text] [Related]
2. Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework.
Angelis A; Linch M; Montibeller G; Molina-Lopez T; Zawada A; Orzel K; Arickx F; Espin J; Kanavos P
Soc Sci Med; 2020 Feb; 246():112595. PubMed ID: 31874372
[TBL] [Abstract][Full Text] [Related]
3. Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting.
Angelis A; Montibeller G; Hochhauser D; Kanavos P
BMC Med Inform Decis Mak; 2017 Oct; 17(1):149. PubMed ID: 29073892
[TBL] [Abstract][Full Text] [Related]
4. Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework.
Angelis A; Kanavos P
Soc Sci Med; 2017 Sep; 188():137-156. PubMed ID: 28772164
[TBL] [Abstract][Full Text] [Related]
5. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
[TBL] [Abstract][Full Text] [Related]
6. Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis.
Angelis A; Thursz M; Ratziu V; O'Brien A; Serfaty L; Canbay A; Schiefke I; Costa JBE; Lecomte P; Kanavos P
Med Decis Making; 2020 Aug; 40(6):830-845. PubMed ID: 32845234
[No Abstract] [Full Text] [Related]
7. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
8. Multiple Criteria Decision Analysis (MCDA) for evaluating cancer treatments in hospital-based health technology assessment: The Paraconsistent Value Framework.
Campolina AG; Estevez-Diz MDP; Abe JM; de Soárez PC
PLoS One; 2022; 17(5):e0268584. PubMed ID: 35613115
[TBL] [Abstract][Full Text] [Related]
9. Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets.
Brixner D; Maniadakis N; Kaló Z; Hu S; Shen J; Wijaya K
Value Health Reg Issues; 2017 Sep; 13():1-6. PubMed ID: 29073981
[TBL] [Abstract][Full Text] [Related]
10. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
Tony M; Wagner M; Khoury H; Rindress D; Papastavros T; Oh P; Goetghebeur MM
BMC Health Serv Res; 2011 Nov; 11():329. PubMed ID: 22129247
[TBL] [Abstract][Full Text] [Related]
11. Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment.
Angelis A; Kanavos P
Pharmacoeconomics; 2016 May; 34(5):435-46. PubMed ID: 26739955
[TBL] [Abstract][Full Text] [Related]
12. Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art.
Oliveira MD; Mataloto I; Kanavos P
Eur J Health Econ; 2019 Aug; 20(6):891-918. PubMed ID: 31006056
[TBL] [Abstract][Full Text] [Related]
13. Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut).
Guarga L; Badia X; Obach M; Fontanet M; Prat A; Vallano A; Torrent J; Pontes C
Orphanet J Rare Dis; 2019 Jun; 14(1):157. PubMed ID: 31248421
[TBL] [Abstract][Full Text] [Related]
14. Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis.
Kolasa K; Zwolinski KM; Zah V; Kaló Z; Lewandowski T
Orphanet J Rare Dis; 2018 Apr; 13(1):67. PubMed ID: 29703227
[TBL] [Abstract][Full Text] [Related]
15. Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa.
Miot J; Wagner M; Khoury H; Rindress D; Goetghebeur MM
Cost Eff Resour Alloc; 2012 Feb; 10(1):2. PubMed ID: 22376143
[TBL] [Abstract][Full Text] [Related]
16. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
[TBL] [Abstract][Full Text] [Related]
17. HTA and MCDA solely or combined? The case of priority-setting in Colombia.
Castro HE; Moreno-Mattar O; Rivillas JC
Cost Eff Resour Alloc; 2018; 16(Suppl 1):47. PubMed ID: 30455606
[TBL] [Abstract][Full Text] [Related]
18. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
19. Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screening.
Cunich M; Salkeld G; Dowie J; Henderson J; Bayram C; Britt H; Howard K
Patient; 2011; 4(3):153-62. PubMed ID: 21766911
[TBL] [Abstract][Full Text] [Related]
20. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).
Wahlster P; Goetghebeur M; Kriza C; Niederländer C; Kolominsky-Rabas P;
BMC Health Serv Res; 2015 Jul; 15():262. PubMed ID: 26152122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
